BSEInsider Trading / SAST27 Aug 2026 · 27 Aug 2026, 03:31 pm

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 27, 2026 for Aayush Agrawal, trustee ....

Ajanta Pharma Ltd · 532331

✦ AI SummaryPledge

Ajanta Pharma Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a significant acquisition of shares by Aayush Agrawal, trustee, and other related parties.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern6/10
Regulatory Risk7/10
Balance Sheet Risk4/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

CCB51547_60DA_4033_9747_926B443CA2FB_153126.pdf

pdf

Download →
View document text
Formfaodtri sclbo�s utPrhreeo tmeort(ots hlse t oecxkc haann&i1td o t hTea rgCeotm E!afnoe�rn cumbroafsn hcaeri ensv/o coafet nicounm brraenlceoeaf/es nec umbr1antn ecreom,fRs � ula3t{1f1 oa}nn 3d(1 2 olfS EB{IS ubstAacngtuilasolifS t hfaoranen sd Takeover} 2R0�1u1l atfons, Namoeft .Thaer Cgoemtp a(nTyCA )j:a Pnhtaar Lmiam ited Namoef t eh StckoE xchanwgheree teh shareso ft htea ertcgo moanavr leti es BdS:&E:N SE Datoerr epor2t.7i0n8g.!2 026 Nameo f thoer omootrPeA Cr o n whose shaernesuc mbrahnsacb eee nc erateredle/as edI/vnoedk:A aYuAsghr a twrasulte ,Aeavus Ah�rawTuarsl t Detaoiftl hrsee leaanscder eaotfei nocnu mbrRaenlce&eaC :sr ee aotfpi loend ge Namoeft hper omotoerPr A(Cwssi) th hi m(•P)r omohtoelrdi intn hgte a rgePtr omohtoelrda ilnrge ady Detaoifel vse pnetrst atioen nicnugm b(r3a)n ce Posetv ehnotl doifn g compa(n1y) encumb(e)2r ed encumbsehrae{rdce rse ation [()2(+3/)r ]el[e(a)2s·e(/3 )] invoca)t·i(o3n)[)(}1 Number% o ft otsahla reN umber %otfo taTly poefe vent Datoef Typoef Reasons Nfuomrb er% o ft otaNla moeft heen tiinwt hyo se Number %o ft otal capital shacraep i(tcarle atiocnr/eraetlieoane/snr ceulmebarsea nncc.uem .bra nce sharef avsohra ernecsu mb.e.r.e d shacraep ital eiln votcia)o en/invoocf(a ptlieodng e/lien/no capital emcumbrandcies posna l undertaking/ oth)e rs GabIsn vestmPevLnttt ds 1,25,aS,31903. 0277 ,70,0020. 22 27,70,00.20. 22 YogeMsA hg ratwrauls,Yt oegee sh Agraw1a,l8 0,78,14174 .47 . Trust J,\annBaA learla wal 0 0.00 RajMesA hg ratwrauls,Rt aejeAe sghr awal 1,801,4788 , 14.47 Trust . . . RaPvA ig ratwrauls,Rt aeAvegi r aTwrauls t 1,27,92,90140 .24 14,731,.31980 14,73,319.01 8 RaPv.iA g rawal 2,85,000 0.2.3 . . . AayuA.\s �A grtarwuaslAt,ae yeuA sghr awal 1,41,12,92141 .219, 35,121,09.2843 P ledRgeel eas1e9 -Aug-2P6l edgeR epayomfe n9t, 76,0000. 78 RBBLa nLkt d 1,25,561,09.2045 Trust loan 1,25,56,1902.40 5P ledCgree ati2o·1nA ug-26P ledge Adition9a,l2 0,0000. 74 360 POrnieLm ted 1,34,76,1902.47 9 Security AayuMs.Ah g rawal 30,000 0.02 0 0.00 30,0000 .02 GanEgxap orretpsr esbeyin tptsae rdt ners 33,48,261 2.68 YogeAsghr aRwaajlAe,gs rha &wR aalv i Agrawal Date:2 7/08/2026 'Thnea moef as-ltlh per omottheeirsrhs a,r ehoIlntd htiean rgtcg oemnpy,ar Iidt hieprl edsgheda rehao soln tdehir negpo rtdiantsgeohu ladp paeri nth et abilrerese pctoifwv hete htehre ayrr ee pnogro tnti hdea toefe vneto rn ot. •• eF)(ijornrp lfeot;rh peu rpoofcs oel laftoleror aatnlas kb eytn h ceo mpapenrys,o bnoarlr otwhiinprgad,rtp yl edgeet,c . -�TwhoiusIl ndc l1u1daoemfb e o tthhl ee nadnetdrh ten.J stweheom ayh olsdha driersec otrol nby e hoaflt fhl ee nder.